SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Abgenix, Inc. (ABGX) -- Ignore unavailable to you. Want to Upgrade?


To: nigel bates who wrote (249)7/4/2003 7:56:23 PM
From: Miljenko Zuanic  Read Replies (1) | Respond to of 590
 
Indeed, there are many reasons for AMGN to look at.

However, ABGX have sufficient amount of cash to support ABX-EGF program, find partners for few candidates and keep most promising until they can get right deal. Two years for now they may be good munch for AMGN, and I hope at favorable price for shareholders.

Miljenko